"Carbamazepine should not be used in patients with a history of previous bone marrow depression, hypersensitivity to the drug, or known sensitivity to any of the tricyclic compounds, such as amitriptyline, desipramine, imipramine, protriptyline and nortriptyline. Likewise, on theoretical grounds its use with monoamine oxidase inhibitors is not recommended. Before administration of carbamazepine, MAO inhibitors should be discontinued for a minimum of 14 days, or longer if the clinical situation permits.
Coadministration of carbamazepine and nefazodone may result in insufficient plasma concentrations of nefazodone and its active metabolite to achieve a therapeutic effect. Coadministration of carbamazepine with nefazodone is contraindicated.
Coadministration of Carbatrol is contraindicated with delavirdine due to the potential for loss of virologic response and possible resistance to delavirdine or to the class of non-nucleoside reverse transcriptase inhibitors."
More info: https://www.drugs.com/pro/carbatrol.html
- Carbatrol Information for Consumers
- Carbatrol Information for Healthcare Professionals (includes dosage details)
- Side Effects of Carbatrol (detailed)
Search for questions
Still looking for answers? Try searching for what you seek or ask your own question.
Posted 21 Jun 2010 • 1 answer
Posted 23 Apr 2016 • 2 answers
Posted 20 Jan 2017 • 0 answers
Posted 4 Feb 2017 • 1 answer
Posted 2 Dec 2017 • 0 answers